Jarisch R, Eibl M, Sandor I, Boltz A
Allergy. 1981 Feb;36(2):99-105. doi: 10.1111/j.1398-9995.1981.tb04103.x.
Dialysable transfer factor (TF) was given in 10 paediatric patients with severe atopic dermatitis (AD). Ten patients with AD, matched for age and severity of disease, served as controls. Prior to the therapy with TF and at weekly intervals thereafter, T- and B-cells in the blood, PHA-stimulation, total IgE and specific IgG antibodies to inhalant and food antigens were determined. Therapy with TF was followed by IgE depression in 8/10 patients and was most pronounced in three patients with initially high levels. Some decrease of IgE levels was seen in four controls also, none of them, however, fell to normal levels as was seen in two of the treated patients. Specific IgE levels decreased slightly, but always remained within the pathological range. T-cell counts in the blood increased in 2/10 cases as well as PHA-stimulation, B-cells counts remained within normal limits. Clinical improvement was seen in one patient, five improved slightly and four remained unchanged. Our results indicate, that transfer factor can lower total IgE levels in cases with atopic dermatitis. The effect is most marked in patients with high total IgE levels. Skin involvement, however, does not closely follow in vitro findings.
对10例重度特应性皮炎(AD)患儿给予可透析转移因子(TF)治疗。另外选取10例年龄和病情严重程度相匹配的AD患儿作为对照。在给予TF治疗前及之后每周测定血液中的T细胞和B细胞、PHA刺激反应、总IgE以及针对吸入性和食物抗原的特异性IgG抗体。TF治疗后,10例患者中有8例IgE降低,其中3例初始水平较高者最为明显。4例对照患者的IgE水平也有一定程度下降,但均未降至正常水平,而2例接受治疗的患者降至正常。特异性IgE水平略有下降,但始终处于病理范围内。10例中有2例血液中T细胞计数增加,PHA刺激反应也增强,B细胞计数保持在正常范围内。1例患者临床症状改善,5例略有改善,4例无变化。我们的结果表明,转移因子可降低特应性皮炎患者的总IgE水平。对总IgE水平高的患者效果最为显著。然而,皮肤受累情况与体外检测结果并不密切相关。